Login to Your Account

Novagali Pharma Raises EUR26M In Series C Round

By James Etheridge

Wednesday, April 26, 2006
PARIS - Novagali Pharma closed a third funding round in which it raised €26 million from its existing investors and two newcomers, bringing to €44 million (US$54.6 million) the total funding it has raised since it was founded in August 2000. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription